News HeadLines – 2011

• Opening of an additional GMP production facility dedicated to mammalian cell culture.
The French regulatory authority (AFSSAPS) authorized manufacturing operations including the production of biotechnology products, immunology products and extracted products of animal or human origin
Press release

• PX'Therapeutics Licenses RIBOVAX's SEBVI Technology for the Development and Manufacturing of Fully Human Monoclonal Antibodies
Press release

Events

We will be attending the following events.
Please do not hesitate to come and see us at:

• BioEurope – Milan, Italy – March 14-16^th
• 3rd Annual antibody congress – Beijing, China – March 23-25^th
• Biovision - Lyon, France - March 27-29^th
• Vaccine forum 2011 – Barcelona, Spain – May 11-13^th
• ILSI-Biomed – Tel-Aviv, Israel – May 23-25^th
• Epic – London, England – June 15^th
• Bio International Convention – Washington, USA – June 27-30^th
• BioEurope - Dusseldorf, Germany – October 31^st to November 2^nd
• World Vaccine Congress - Lyon, France - October 10-14^th
• 4ème Rencontres Industriels/Académiques du CLARA - Lyon, France - December 7th